UroToday shares a study on GLP-1 drugs and bladder and kidney cancer outcomes
A propensity-matched analysis looks at whether GLP-1 receptor agonist use is tied to cancer incidence and overall survival in bladder and renal cell cancers.
Recap by typeshit. Post by UroToday.com on X.